Putnam Associates, a strategic management healthcare consultancy with offices in Boston and San Francisco, has recently opened a new office in New York.
Putnam also plans to recruit experienced associates and management consultants across a number of roles for the new office, with five team members relocating to the area.
The consultancy employs over 130 people and offers specialist services to life science organisations with particular strengths in product commercialisation, pricing and reimbursement and market access strategy.
Commenting on the new office, Remco op den Kelder, CEO said: “We became part of a leading global life science services company (UDG Healthcare) in early 2019 and this created a number of opportunities for Putnam to leverage its infrastructure and resources and grow around the world.
“Our New York office is part of a strategy to increase our global footprint and offer more localised support to our clients.
“It will also enable us to add to our talented teams as we look to recruit at every level, from senior leaders and experienced management consultants to graduates looking to start a career in the sector.
“The life sciences is an exciting industry to be a part of, the work we do is impactful and we work in a very dynamic environment so we’re always searching for top performers to join us.”
Founded in 1988, Putnam has grown to become a respected advisory brand for biopharmaceutical companies and attracts top class talent from several of the leading US universities.
Over the past 10 years, Putnam has advised on the commercialisation of several products that have achieved blockbuster sales status in the US.
About Putnam
Founded in 1988, Putnam Associates has been serving global biopharmaceutical, diagnostics, and medical device clients, along with private equity and venture capital clients, providing world class strategic advice based on sophisticated, robust analytics. The company provides customized, actionable recommendations that draw on robust problem framing, cutting-edge methodologies, deep therapeutic area knowledge, extensive global networks of health care stakeholders, and expert synthesis across scientific, clinical, and business disciplines.
Putnam’s work is dedicated to maximizing the value of the pharmaceutical, biotechnology, diagnostic and device products serving clients who market many of the world’s best-known biopharmaceuticals
For more information, please go to https://www.putassoc.com/
About Ashfield
Ashfield, part of UDG Healthcare plc, is a global leader in commercialisation services for the healthcare industry. We partner with our clients across Advisory, Healthcare Communications, Commercial, Patient Solutions and Medical Affairs to build creative, scalable and tailored health solutions that are executed flawlessly, to deliver positive outcomes for patients and add value to your business. The company has more than 7,000 employees, operates in 24 countries across Europe, North America, South America and Asia and works with more than 250 businesses, including all of the world’s top 25 pharmaceutical companies.
Its mission is to partner with its clients, helping to improve lives by ensuring healthcare professionals and patients get the medicines, knowledge and support they need.
Ashfield provides contract sales teams, customer service reps, medical science liaison officers, remote detailing, nurse educators, medical information, healthcare communications, market access, market research, training, event management, digital, creative, pharmacovigilance, audit and advisory services.
For more information, go to www.ashfieldhealthcare.com.
About UDG Healthcare plc
UDG Healthcare plc (LON: UDG) is a leading international partner of choice delivering advisory, communication, commercial, clinical and packaging services to the healthcare industry, employing over 9,000 people with operations in 26 countries and delivering services in over 50 countries.
UDG Healthcare plc operates across two divisions: Ashfield and Sharp.
Ashfield is a global leader in advisory, communication, commercial and clinical services for the pharmaceutical and healthcare industries. It focuses on supporting healthcare professionals and patients at all stages of the product life cycle. The division provides field and contact centre sales teams, healthcare communications, patient support, audit, advisory, medical information and event management services to over 300 healthcare companies.
Sharp is a global leader in contract commercial packaging and clinical trial packaging services for the pharmaceutical and healthcare industries, operating from state-of the-art facilities in the US and Europe.
The company is listed on the London Stock Exchange and is a constituent of the FTSE 250. For more information, please go to: www.udghealthcare.com
